Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharma Smeden ApS
APS
Dissolved
CVR 43831321
Davrekildevej 4
Repair and maintenance of fabricated metal products · NACE 3311
Est. 2023
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 480K
EBITDA margin
100.0%
Equity ratio
23.8%
Financial strength
Net profit 2024
DKK 373K
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 480K
—
EBITDA
DKK 480K
—
Net profit
DKK 373K
—
Total assets
DKK 1,7M
+4244%
Equity
DKK 413K
+933%
Employees
—
—
Company information
Legal name
Pharma Smeden ApS
CVR number
43831321
Legal form
Anpartsselskab
NACE code
3311 · Repair and maintenance of fabricated metal products
Founded
1. februar 2023
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af 1 direktør
Contact
Address
Davrekildevej 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Repair and maintenance of fabricated metal products
Companies in Kalundborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
0
480
Staff expenses
-0
-0
EBITDA
0
480
Depreciation & amort.
-0
-0
EBIT
0
480
Net financials
0
0
Profit before tax
0
480
Tax
-0
107
Net profit
0
373
Balance sheet
DKK thousands
Item
2023
2024
Total assets
40
1.738
Equity
40
413
Long-term debt
0
0
Short-term debt
0
1.324
Total debt
0
1.324
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2023
2024
Equity ratio
23.8%
This company
38.2%
Market median
-38% vs market
2023
2024
Return on equity
90.3%
This company
18.4%
Market median
+391% vs market
2023
2024
Net profit margin
77.8%
This company
8.1%
Market median
+860% vs market
2023
2024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
2023
2024
Debt / equity
3.21×
This company
0.62×
Market median
-418% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-02-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Allan Trebbien
Individual
100%
100%
2023
Holding 2023 ApS
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Pharma Smeden ApS also hold positions in
0
other companies.
Person
Role here
Other companies